← Evidence map

ArticleCancer discovery2016

Correction: Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping.

PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016
2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26896094